Bares Capital Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-450,000
Closed -$3.39M 30
2024
Q1
$3.39M Hold
450,000
0.13% 31
2023
Q4
$4.17M Sell
450,000
-250,000
-36% -$2.04M 0.16% 32
2023
Q3
$7.08M Sell
700,000
-80,000
-10% -$955K 0.3% 34
2023
Q2
$9.75M Buy
780,000
+330,000
+73% +$3.93M 0.34% 34
2023
Q1
$5.25M Sell
450,000
-2,400
-0.5% -$30.6K 0.19% 39
2022
Q4
$4.81M Hold
452,400
0.18% 36
2022
Q3
$4.39M Buy
452,400
+200,000
+79% +$2.65M 0.17% 37
2022
Q2
$3.66M Buy
252,400
+9,553
+4% +$163K 0.13% 35
2022
Q1
$6.35M Buy
242,847
+103,542
+74% +$2.94M 0.15% 35
2021
Q4
$5.52M Hold
139,305
0.11% 34
2021
Q3
$6.97M Buy
+139,305
New +$7.6M 0.13% 34

Other funds holding HCAT